NCT05150392View on ClinicalTrials.gov

An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization

PHASE3CompletedINTERVENTIONAL
Enrollment

1,193

Participants

Timeline

Start Date

July 11, 2018

Primary Completion Date

August 11, 2018

Study Completion Date

August 14, 2020

Conditions
Varicella
Interventions
BIOLOGICAL

Investigational live attenuated varicella vaccine

The investigational vaccine was manufactured by Sinovac (Dalian) Vaccine Technology Co., Ltd.And the live varicella-zoster virus in 0·5 mL of sucrose, sodium glutamate,sodium chloride,potassium chloride,sodium dihydrogen phosphate, potassium dihydrogen phosphate and injection water per injection

Trial Locations (1)

461700

Xiangfu County Center for Disease Control and Prevention, Kaifeng

All Listed Sponsors
lead

Sinovac (Dalian) Vaccine Technology Co., Ltd.

INDUSTRY

NCT05150392 - An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization | Biotech Hunter | Biotech Hunter